Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Almirall S.A.
LBTSFCurrent price
9.51 USD
0 USD (0.00%)
Last closed
8.77 EUR
Company
www.almirall.com
ISIN
ES0157097017
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
MC
Capitalization
1 957 194 656 EUR
Yield for 12 month
+0.40 %
1Y
3Y
5Y
10Y
15Y
LBTSF
Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain. Address: Ronda General Mitre, 151, Barcelona, Spain, 08022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.49 EURP/E ratio
–Dividend Yield
1.72 %Current Year
+905 910 579 EUR
Last Year
+870 077 320 EUR
Current Quarter
+501 151 587 EUR
Last Quarter
+250 768 304 EUR
Current Year
+585 999 567 EUR
Last Year
+686 166 788 EUR
Current Quarter
+205 185 521 EUR
Last Quarter
+159 854 715 EUR
Key Figures LBTSF
1 year
3 years
5 years
10 years
EBITDA
150 875 242 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.11 %
PEG Ratio
0.2956
Return On Equity TTM
-2.33 %
Wall Street Target Price
12.49 EUR
Revenue TTM
939 000 319 EUR
Book Value
7.02 EUR
Revenue Per Share TTM
Dividend Share
0.19 EUR
Quarterly Revenue Growth YOY
7 %
Dividend Yield
1.72 %
Gross Profit TTM
680 975 038 EUR
Earnings per share
-0.19 EUR
Diluted Eps TTM
-0.19 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
65.6 %
Profit Margin
-3.77 %
Dividend Analytics LBTSF
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
112 %Dividend History LBTSF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.18
Ex Dividend Date
17.05.2024
Forward Annual Dividend Yield
2.02 %
Last Split Factor
47:46
Payout Ratio
1.86 %
Last Split Date
14.09.2020
Dividend Date
–
Stock Valuation LBTSF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
15.4321
Enterprise Value Revenue
2.1818
Price Sales TTM
2.0843
Enterprise Value EBITDA
16.4327
Price Book MRQ
1.3062
Financials LBTSF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LBTSF
For 52 weeks
7.79 EUR
10.12 EUR
50 Day MA
8.93 EUR
Shares Short Prior Month
–
200 Day MA
8.94 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart